Linguo Gu
Overview
Explore the profile of Linguo Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gu L, Chen H, Xia Z, Qing B, Yuan Y
Front Immunol
. 2025 Jan;
15:1500996.
PMID: 39763670
Pulmonary large cell carcinoma (LCC) is a rare and aggressive subtype of non-small cell lung cancer (NSCLC) with poor prognosis. Surgical resection remains the cornerstone of treatment for resectable LCC;...
2.
Wang J, Xia Z, Qing B, Chen Y, Gu L, Chen H, et al.
Mol Med
. 2024 Nov;
30(1):228.
PMID: 39580448
Background: Pulmonary fibrosis (PF) is a progressive and difficult-to-heal lung disease that poses a significant threat to human life and health. This study aimed to investigate the potential pathological mechanisms...
3.
Chen H, Xia Z, Qing B, Gu L, Chen Y, Wang J, et al.
Int Immunopharmacol
. 2024 Nov;
143(Pt 3):113572.
PMID: 39515041
Idiopathic pulmonary fibrosis (IPF) is a chronic pulmonary disease with unknown pathogenesis and poor prognosis. PANoptosis, a newly identified form of inflammatory programmed cell death, has been implicated in various...
4.
Gu L, Xia Z, Qing B, Wang W, Chen H, Wang J, et al.
Front Immunol
. 2024 Apr;
15:1338025.
PMID: 38558798
Objective: To examine the correlation between SIRI and the probability of cardiovascular mortality as well as all-cause mortality in individuals with chronic kidney disease. Methods: A cohort of 3,262 participants...
5.
Chen H, Xia Z, Qing B, Wang W, Gu L, Chen Y, et al.
Front Immunol
. 2023 Apr;
14:1119139.
PMID: 37051233
Background: IPF is an undetermined, progressive lung disease. Necroptosis is a type of programmed apoptosis, which involved in the pathogenesis of lung diseases like COPD and ARDS. However, necroptosis in...
6.
Gu L, Xia Z, Qing B, Chen H, Wang W, Chen Y, et al.
Front Cardiovasc Med
. 2022 Jun;
9:847998.
PMID: 35647067
Objective: To further supplement the previous research on the relationship between neutrophil-lymphocyte ratio (NLR) and all-cause and cardiovascular mortality, and construct clinical models to predict mortality. Methods: A total number...
7.
Xia Z, Chen M, Qing B, Wang W, Gu L, Yuan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban
. 2021 Dec;
46(10):1172-1176.
PMID: 34911850
Antibody-mediated rejection (AMR) is a rare and serious complication after lung transplantation, with no characteristic of pathological manifestation, no systematic standard treatment, and the poor efficacy and prognosis. We reported...
8.
Qing B, Xia Z, Wang W, Gu L, Chen H, Yuan Y
Ann Transl Med
. 2021 Nov;
9(20):1602.
PMID: 34790808
A growing number of ground-glass opacity (GGO) nodules are screened out in lungs. Small GGOs are frequently neither visible nor palpable, thus undetectable during operation. Various nodule localization techniques have...
9.
Xia Z, Qing B, Wang W, Gu L, Chen H, Yuan Y
Thorac Cancer
. 2021 Nov;
12(23):3088-3100.
PMID: 34734680
Lung cancer is the leading cause of cancer-related death worldwide due to diagnosis in the advanced stage and drug resistance in the subsequent treatments. Development of novel diagnostic and therapeutic...